Health Canada drug identification number

DIN 02544571 — MYALEPTA 11.3 MG

MYALEPTA is a powder for solution of Metreleptin marketed by CHIESI FARMACEUTICI S.P.A.. The full Metreleptin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02544571
Brand name
MYALEPTA
Active ingredient
Metreleptin
Strength
11.3 MG
Dosage form
POWDER FOR SOLUTION
Route
SUBCUTANEOUS
Manufacturer
CHIESI FARMACEUTICI S.P.A.
Health Canada status
MARKETED
Drug class
Recombinant human leptin analog (leptin replacement therapy)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Metreleptin products

DINBrandStrengthFormManufacturerStatus
02544555 MYALEPTA 3 MG POWDER FOR SOLUTION CHIESI FARMACEUTICI S.P.A. MARKETED
02544563 MYALEPTA 5.8 MG POWDER FOR SOLUTION CHIESI FARMACEUTICI S.P.A. MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.